# Exploring Protein Misfolding in Amyotrophic Lateral Sclerosis: Structural and Functional Insights

**Authors:** Ouliana Ivantsik, Themis P. Exarchos, Aristidis G. Vrahatis, Panagiotis Vlamos, Marios G. Krokidis

PMC · DOI: 10.3390/biomedicines13051146 · Biomedicines · 2025-05-09

## TL;DR

This paper explores how protein misfolding contributes to amyotrophic lateral sclerosis (ALS), a neurodegenerative disease, and highlights factors that lead to protein aggregation.

## Contribution

The paper provides a detailed analysis of the distinct factors causing protein misfolding in ALS, offering insights into disease mechanisms.

## Key findings

- Protein misfolding and aggregation are central to the progression of ALS.
- Factors like mutations and chaperone machinery failures contribute to protein misfolding in ALS.
- Understanding these mechanisms could lead to new therapeutic strategies for ALS.

## Abstract

Protein functionality depends on its proper folding, making protein misfolding crucial for the function of proteins and, by extension, cells and the whole organism. Increasing evidence supports the role of protein misfolding in the pathogenesis of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). ALS is a rapidly progressive disease diagnosed at a prevalence of 5 cases per 100,000, with approximately 2–3 patients per 100,000 diagnosed each year. To date, there is no cure, and the disease usually leads to death within 2 to 5 years from diagnosis. There are two types of the disorder: familial ALS (fALS), accounting for approximately 10% of cases, and sporadic (sALS), accounting for the remaining 90%. The hallmark of ALS, regardless of type, is the protein aggregates found in patients’ tissues. This suggests that the disruption of proteostasis plays a critical role in the development of the disease. Herein, we stress the distinct factors that lead to protein misfolding and aggregate formation in ALS. Specifically, we highlight several triggering factors affecting protein misfolding, namely mutations, errors in the processes of protein production and trafficking, and failures of folding and chaperone machinery. Gaining a deeper understanding of protein aggregation will improve our comprehension of disease pathogenesis and potentially uncover new therapeutic approaches.

## Linked entities

- **Diseases:** amyotrophic lateral sclerosis (MONDO:0004976)

## Full-text entities

- **Diseases:** neurodegenerative diseases (MESH:D019636), ALS (MESH:D000690), death (MESH:D003643), fALS (MESH:C531617)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12109280/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12109280/full.md

## References

122 references — full list in the complete paper: https://tomesphere.com/paper/PMC12109280/full.md

---
Source: https://tomesphere.com/paper/PMC12109280